These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26894771)

  • 21. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
    Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
    Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression profiles of melanogenesis-related genes and proteins in acquired melanocytic nevus.
    Hashimoto Y; Ito Y; Kato T; Motokawa T; Katagiri T; Itoh M
    J Cutan Pathol; 2006 Mar; 33(3):207-15. PubMed ID: 16466507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis.
    Jungbluth AA; Iversen K; Coplan K; Williamson B; Chen YT; Stockert E; Old LJ; Busam KJ
    Virchows Arch; 1999 May; 434(5):429-35. PubMed ID: 10389626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMB-45 recognizes stimulated melanocytes.
    Smoller BR; McNutt NS; Hsu A
    J Cutan Pathol; 1989 Apr; 16(2):49-53. PubMed ID: 2668355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions.
    Keller-Melchior R; Schmidt R; Piepkorn M
    J Invest Dermatol; 1998 Jun; 110(6):932-8. PubMed ID: 9620301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas.
    Jungbluth AA; King R; Fisher DE; Iversen K; Coplan K; Kolb D; Williamson B; Chen YT; Stockert E; Old LJ; Busam KJ
    Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):29-34. PubMed ID: 11277411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas.
    Bolander A; Agnarsdóttir M; Strömberg S; Ponten F; Hesselius P; Uhlen M; Bergqvist M
    Cancer Genomics Proteomics; 2008; 5(6):293-300. PubMed ID: 19287070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of TRP-2 in melanogenic melanocytes of human hair.
    Commo S; Gaillard O; Thibaut S; Bernard BA
    Pigment Cell Res; 2004 Oct; 17(5):488-97. PubMed ID: 15357835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bcl-2 expression in human melanocytes and melanocytic tumors.
    van den Oord JJ; Vandeghinste N; De Ley M; De Wolf-Peeters C
    Am J Pathol; 1994 Aug; 145(2):294-300. PubMed ID: 8053490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis.
    King R; Weilbaecher KN; McGill G; Cooley E; Mihm M; Fisher DE
    Am J Pathol; 1999 Sep; 155(3):731-8. PubMed ID: 10487831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium.
    Sedghizadeh PP; Williams JD; Allen CM; Prasad ML
    Med Sci Monit; 2005 Jul; 11(7):BR189-94. PubMed ID: 15990678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melan-A positive dermal cells in malignant melanoma in situ.
    Danga ME; Yaar R; Bhawan J
    J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
    Tacha D; Qi W; Ra S; Bremer R; Yu C; Chu J; Hoang L; Robbins B
    Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.
    Sundram U; Harvell JD; Rouse RV; Natkunam Y
    Mod Pathol; 2003 Aug; 16(8):802-10. PubMed ID: 12920225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RT-PCR detection of tyrosinase, gp100, MART1/Melan-A, and TRP-2 gene transcripts in peripheral blood of melanoma patients.
    Samija M; Juretić A; Solarić M; Samija I; Bingulac-Popović J; Grahovac B; Stanec M; Oresić V
    Croat Med J; 2001 Aug; 42(4):478-83. PubMed ID: 11471202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of tyrosinase-related protein-2, S-100, and Melan A immunoreactivity in canine amelanotic melanomas.
    Choi C; Kusewitt DF
    Vet Pathol; 2003 Nov; 40(6):713-8. PubMed ID: 14608029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo.
    Jäger E; Ringhoffer M; Karbach J; Arand M; Oesch F; Knuth A
    Int J Cancer; 1996 May; 66(4):470-6. PubMed ID: 8635862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.